Complications after administration of contrast medium in high-risk patients;Komplikationen nach Applikation von Rontgen-Kontrastmitteln bei Risikopatienten

Deutsche Medizinische Wochenschrift

Volumn 121, Issue 47, 1996, Pages 1475-1479

  Liebl, R ^a,b   Kramer B K ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b KfH Dialysezentrum   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DIATRIZOATE; IOBITRIDOL; IOHEXOL; IOPAMIDOL; IOXAGLIC ACID; MEGLUMINE IOTALAMATE; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL BLOCKING AGENT; ENDOTHELIN RECEPTOR; THEOPHYLLINE;

COMPLICATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; RADIOLOGY; REVIEW; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; DETOXIFICATION; DRUG ANTAGONISM; HEMOFILTRATION; PERITONEAL DIALYSIS; RENAL REPLACEMENT THERAPY; RISK FACTOR; TIME;

ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL BLOCKERS; CONTRAST MEDIA; HEMOFILTRATION; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; RECEPTORS, ENDOTHELIN; RENAL DIALYSIS; RISK FACTORS; SORPTION DETOXIFICATION; THEOPHYLLINE; TIME FACTORS;

EID: 0029904653     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043171     Document Type: Review

References (47)

1. Almén, T.: The etiology of contrast medium reactions. Invest. Radiol. 29, Suppl. 1 (1994), 37-45.
2. Bahlmann, J., H.L. Krüskemper: Elimination of iodine-containing contrast media by haemodialysis. Nephron 10 (1973), 250-255.
3. Barrett, B.J., P.S. Parfrey, H.M. Vavasour, J. McDonald, G. Kent, D. Hefferton, F. O'Dea, E. Stone, R. Reddy, P.J. McManamon: Contrast nephropathy in patients with impaired renal function: High versus low osmolar media. Kidney int. 41 (1992), 1274-1279.
4. Barrett, B.J., E.J. Carlisle: Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188 (1993), 171-178).
5. Barrett, B.J.: Contrast nephrotoxicity. J. Amer. Soc. Nephrol. 5 (1994), 125-137.
6. Bettmann, M.A.: The evaluation of contrast-related renal failure. Amer. J. Roentgenol. 157 (1991), 66-68.
7. Birk, H.-W., E. Feuring, G. Schütterle: Tubulotoxische Wirkung von Röntgen-Kontrastmitteln bei Diabetikern mit normaler Nierenfunktion. Dtsch. med. Wschr. 121 (1996), Sonderheft 1, 122 (Abstr.).
8. Brady, H.R., G.G. Singer: Acute renal failure. Lancet 346 (1995), 1533-1540.
9. Carraro, M., W. Mancini, M. Artero, F. Stacul, M. Grotto, M. Cova, L. Faccini: Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration. Nephrol. dialys. Transplant. 11 (1996), 444-448.
10. Conlon, P.J., S.J. Schwab: Time to abandon nonionic contrast? J. Amer. Soc. Nephrol. 5 (1994), 123-124.
11. th ed. (Little, Brown & Co: Boston 1993), S. 1187-1198.
12. Dencausse, A., C. Chambon, X. Violas, B. Bonnemain: Comparative study of the dialysability of iobitridol and iohexol in the rat with impaired renal function. Acta radiol. 36 (1995), 545-548.
13. Deray, G., M.F. Bellin, H. Boulechfar, B. Baumelou, F. Foskas, A. Baumelou, J. Grellet, C. Jacobs: Nephro-toxicity of contrast media in high risk patients with renal insufficiency. Comparison of low-and high-osmolar contrast agents. Amer. J. Nephrol. 11 (1991), 309-312.
14. Donnelly, P.K., N. Burwell, A. McBurney, J.W. Ward, J. Walls, E.M. Watkin: Clearance of iopamidol, a non-ionic contrast medium, by CAPD in patients with end-stage renal disease. Brit. J. Radiol. 65 (1992), 1108-1113.
15. Donnelly, P.K., N. Burwell, A. McBurney, J.W. Ward, E.M. Watkin: Hemodialysis and iopamidol clearance after subclavian venography. Invest. Radiol. 28 (1993), 629-532.
16. Donnelly, P.K., B. Williams, E.M. Watkin: Polyarthropathy. A delayed reaction to low osmolality angiographic contrast medium in patients with end stage renal disease. Europ. J. Radiol. 17 (1993), 130-132.
17. Donnelly, P., N. Burwell, A. McBurney, J.W. Ward, J. Walls, E.M. Watkins: Iopamidol clearance in CCPD patients. Perit. Dial. Int. 14 (1994), 194-195.
18. Erley, C.M., S.H. Duda: Nephropathie durch Kontrastmittel. Dtsch.med. Wschr. 120 (1995), 806-810.
19. Evans, J.R., R.E. Cutler, S.C. Forland: Pharmacokinetics of Iothalamate in endstage renal disease. J. Clin. Pharmacol. 28 (1988), 826-830.
20. Gouge, S.F., J. Moore, F. Atkins, P. Hirszel: Radiocontrast removal by dialysis membranes. Blood Purif. 9 (1991), 182-187.
21. rd EDTA Congress (Amsterdam 1996), abstr. S. 206.
22. Harasawa, H., C. Yamazaki, K. Masuko: Side effects and pharmacokinetics of nonionic iodinated contrast medium in hemodialized patients. Nippon Acta Radiol. 50 (1990), 1524-31.
23. Huhn, H.-W., J. Tönnis, E. Schmidt: Elimination von Röntgen-Kontrastmittel durch Hämodialyse. Nieren- u. Hochdruckkr. 22 (1993), 45-52.
24. Kleinknecht D, P. Landais, B. Goldfarb: Pathophysiology and clinical aspects of drug-induced tubular necrosis in man. Contrib. Nephrol. 55 (1987), 145-158.
25. Lautin, E.M., N.J. Freeman, A.M. Schoenfeld, C.W. Bakal, N. Haramati, A.C. Friedman, J.L. Lautin, S. Braha, E.G. Kadish, S. Sprayregen, I. Belizon: Radiocontrast-associated renal dysfunction. Incidence and risk factors. Amer. J. Roentgenol. 157 (1991), 49-57.
26. Lautin, E.M., N.J. Freeman, A.H. Schoenfeld, C.W. Bakal, N. Haramiti, A.C. Friedman, J.L. Lautin, S. Braha, E.G. Kadish, S. Sprayregen, I. Belizon: Radiocontrast-associated renal dysfunction. A comparison of lower-osmolality and conventional high-osmolality contrast media. Amer. J. Roentgenol. 157 (1991), 59-65.
27. Lehnen, Th., T. Schäffner, K. Gondolf, P. Schollmeyer, E. Keller: Hämodialyse nach Kontrastmittelgabe bei Patienten mit chronischer Niereninsuffizienz. Verminderte Nephrotoxizität durch beschleunigte Pharmakoelimination? Nieren- u. Hochdruckkr. 24 (1995), 523 (Abstr.).
28. Lufft, V., L. Hoogestraat-Lufft, D. Egbeyong, L. Fels, K.M. Koch, M. Galanski, C.J. Olbricht: Comparison of nephrotoxicity induced by contrast media (CM) intraarterial (ia) versus intravenous (iv): A prospective randomized trial. J. Amer. Soc. Nephrol. 6 (1995), 470 (Abstr.).
29. Manske, C.L., J.M. Sprafka, J.T. Strony, Y. Wang: Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Amer. J. Med. 69 (1990), 615-620.
30. McCarthy, C.S., J.A. Becker: Multiple myeloma and contrast media. Radiology 183 (1992), 519-521.
31. Moon, S.S., S.-OE. Bäck, J. Kurkus, P. Nilsson-Ehle: Hemodialysis for elimination of the nonionic contrast medium Iohexol after angiography in patients with impaired renal function. Nephron 70 (1995), 430-437.
32. Morton, H.L.: Temporary suppression of urine following double pyelography. Trans.Amer. Ass. gen.-urin. Srgns (Baltimore) 15 (1922), 87-105.
33. Mudge, G.H.: Nephrotoxicity of urographic radiocontrast drugs. Kidney int. 18 (1980), 540-552.
34. Muruve, D.A., T.I. Steinman: Contrast-induced encephalopathy and seizures in a patient with chronic renal insufficiency. Clin. Nephrol. 45 (1996), 406-409.
35. Parfrey, P.S., S.M. Griffiths, B.J. Barren, M.D. Paul, M. Genge, J. Withers, N. Farid, P.J. McManamon: Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. New Engl. J. Med. 320 (1989), 143-149.
36. Porter, G.A.: Contrast-associated nephropathy: Presentation, pathophysiology and management. Miner. Electrolyte Metab. 20 (1994), 232-243.
37. Rivera, M., J.L. Teruel, J.C. Castano, G. Garcia Otero, J. Ortulo: Iodine-Induced Sialadenitis. Report of 4 cases and review of the literature. Nephron 63 (1993), 466-467.
38. Rudnick, M.R., J.S. Berns, R.M. Cohen, S. Goldfarb: Nephrotoxic risks of renal angiography. Contrast media-associated nephrotoxicity and atheroembolism. A critical review. Amer. J. Kidney Dis. 24 (1994), 713-727.
39. Russo, D., R. Minutolo, B. Cianciaruso, B. Memoli, G. Conte, L. DeNicola: Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J. Amer. Soc. Nephrol. 6 (1995), 1451-8.
40. Scherberich, J.E., J. Kollath, H.E. Riemann: Unerwünschte Kontrastmittelwirkungen an der Niere. In Peter, P.E., E. Zeitler (Hrsg.): Röntgenkontrastmittel. (Springer: Berlin 1991), S. 69.
41. Solomon, R., C. Werner, D. Mann, J. D'Elia, P. Silva: Effects of saline, mannitol, and furosemid on acute decreases in renal function induced by radiocontrast agents. New Engl. J. Med. 331 (1994), 1416-1420.
42. Thadhani R., M. Pascual, J.V. Bonventre: Acute renal failure. New Engl. J. Med. 334 (1996), 1448-1460.
43. Vogl, T.J., B. Hefele-Roedel, E. Held: Renale Komplikationen durch jodhaltige Kontrastmittel in der bildgebenden Diagnostik. Dtsch.Ärztebl.89 (1992), A1333-1338.
44. Waaler, A., M. Svaland, P. Fauchald, J.A. Jakobsen, F. Kolmannskog, K.J. Berg: Elimination of Iohexol, a low osmolar nonionic contrast medium, by hemodialysis in patients with chronic renal failure. Nephron 56 (1990), 81-85.
45. Weinstein, J.-M., S. Heyman, M. Brezis: Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 62 (1992), 413-415.
46. Weisberg, L.S., P.B. Kurnik, B.R.C. Kurnik: Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney int. 45 (1994), 259-265.
47. Younathan, C.M., J.V. Kaude, M.D. Cook, G.S. Shaw, J.C. Peterson: Dialysis is not indicated immediately after administration of non-ionic contrast agents in patients with end-stage renal disease treated by maintenance dialysis. Amer. J. Roentgenol. 163 (1994), 969-71.